Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10000571 Anti-FGFR3 antibodies and methods using same

Patent 10000571 was granted and assigned to Genentech on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100005710

Patent Inventor Names

Christian Wiesmann0

Yan Wu0

Avi Ashkenazi0

Jing Qing0

Date of Patent

June 19, 2018

Patent Application Number

152661050

Date Filed

September 15, 2016

Patent Citations Received

‌

US Patent 11931420 Combination therapies using an anti-BCMA antibody drug conjugate (ADC) in combination with a gamma secretase inhibitor (GSI)

‌

US Patent 11052133 Glucose responsive insulins

‌

US Patent 11505611 FGFR3 antibodies and methods of use

Patent Primary Examiner

‌

Hong Sang

Patent abstract

The invention provides FGFR3 antibodies, and compositions comprising and methods of using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10000571 Anti-FGFR3 antibodies and methods using same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API